Published in J Clin Invest on August 01, 1954
Autoregulation of cerebral blood flow: influence of the arterial blood pressure on the blood flow through the cerebral cortex. J Neurol Neurosurg Psychiatry (1966) 2.15
Role of hypotension in the genesis of transient focal cerebral ischaemic attacks. Br Med J (1963) 1.43
Cortical blood flow in controlled hypotension as measured by thermal diffusion. J Neurol Neurosurg Psychiatry (1973) 0.96
Autoregulation of cerebral blood flow during controlled hypotension in baboons. J Neurol Neurosurg Psychiatry (1976) 0.89
Effect of acute hypoxia on blood pressure and electroencephalogram of newborn babies. Arch Dis Child (1969) 0.88
The Use of Hypotensive Anesthesia in Radical Mastectomy. Ann Surg (1960) 0.84
Changes in regional oxygen consumption and blood flow with induced hypotension during extracorporeal perfusion. Ann Surg (1962) 0.78
Acute controlled hypotension and EEG in patients with hypertension and cerebrovascular disease. J Neurol Neurosurg Psychiatry (1971) 0.77
Relationship between Hypotension and Cerebral Ischemia during Hemodialysis. J Am Soc Nephrol (2017) 0.75
THE EFFECTS OF ALTERED ARTERIAL TENSIONS OF CARBON DIOXIDE AND OXYGEN ON CEREBRAL BLOOD FLOW AND CEREBRAL OXYGEN CONSUMPTION OF NORMAL YOUNG MEN. J Clin Invest (1948) 22.75
THE NITROUS OXIDE METHOD FOR THE QUANTITATIVE DETERMINATION OF CEREBRAL BLOOD FLOW IN MAN: THEORY, PROCEDURE AND NORMAL VALUES. J Clin Invest (1948) 22.17
Circulation and metabolism of the human brain in health and disease. Am J Med (1950) 3.88
Cerebral blood flow in vascular disease of the brain; with observations on the effects of stellate ganglion block. Am J Med (1950) 2.23
The effects of intravenously administered aminophylline on cerebral circulation and metabolism in man. J Clin Invest (1950) 1.44
The effects of l-epinephrine and l-norepinephrine upon cerebral circulation and metabolism in man. J Clin Invest (1952) 1.44
Vascular dynamics in controlled hypotension; a study of cerebral and renal hemodynamics and blood volume changes. Ann Surg (1953) 1.40
The effect of intramuscular dihydroergocornine on the cerebral circulation in normotensive patients. J Pharmacol Exp Ther (1950) 1.35
Effect of hexamethonium chloride on cardiovascular and renal hemodynamics and on electrolyte excretion. J Pharmacol Exp Ther (1952) 1.17
Factors maintaining cerebral circulation during gravitational stress. J Clin Invest (1951) 1.05
Malignant hypertension and hypertensive encephalopathy. Am J Med (1953) 1.04
Septic arthritis as a complication of orally given steroid therapy. J Am Med Assoc (1957) 2.64
The effects of dihydroergocornine on the cerebral circulation of patients with essential hypertension. J Clin Invest (1950) 2.51
Hexamethonium-its effect on glomerular filtration rate, maximal tubular function and renal excretion of electrolytes. J Clin Invest (1953) 2.00
The protective effect of subfiltration arterial pressure on the kidney. Surg Forum (1956) 1.82
[Pharmacodynamics of chlorothiazide (Diuril), an orally effective non-mercurial diuretic agent]. Proc Soc Exp Biol Med (1957) 1.75
Clinical and laboratory observations on chlorothiazide (diuril), an orally effective non-mercurial diuretic agent. AMA Arch Intern Med (1957) 1.71
Pulmonary arteriovenous fistulas; physiologic and clinical considerations. Am J Med (1962) 1.68
The acute effects of hexamethonium on renal hemodynamics in normotensive and hypertensive human subjects. Am J Med Sci (1953) 1.58
Laboratory and clinical observations on chlorpromazine (SKF-2601-A); hemodynamic and toxicological studies. Am J Med Sci (1954) 1.46
Renal and cardiovascular hemodynamic response to ganglionic blockade with pendiomide and a comparison with hexamethonium and arfonad. J Pharmacol Exp Ther (1955) 1.44
Vascular dynamics in controlled hypotension; a study of cerebral and renal hemodynamics and blood volume changes. Ann Surg (1953) 1.40
Some pharmacodynamic effects of 1-hydrazinophthalazine (C-5968) with particular reference to renal function and cardiovascular response. J Pharmacol Exp Ther (1951) 1.36
The effect of intramuscular dihydroergocornine on the cerebral circulation in normotensive patients. J Pharmacol Exp Ther (1950) 1.35
Complications of aortography. Surg Gynecol Obstet (1957) 1.33
Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension. Am J Cardiol (1962) 1.32
Observations on the antihypertensive effectiveness of a new propanediol dicarbamate (W-583). Curr Ther Res Clin Exp (1960) 1.25
Hydrallazine (apresoline) hydrochloride; pharmacological observations and clinical results in the therapy of hypertension. AMA Arch Intern Med (1953) 1.22
Sarcoidosis; a clinical and roentgenological study of 28 cases. Am Rev Tuberc (1950) 1.20
Hypothermia. I. Effect on renal hemodynamics and on excretion of water and electrolytes in dog and man. Ann Surg (1957) 1.20
The effect of treatment on the vascular deterioration associated with hypertension, with particular emphasis on renal function. Am J Med (1958) 1.19
Renal failure. I. The effect of complete renal artery occlusion for variable periods of time as compared to exposure to sub-filtration arterial pressures below 30mm Hg for similar periods. Ann Surg (1957) 1.18
Chlorpromazine jaundice. Gastroenterology (1955) 1.17
Effect of hexamethonium chloride on cardiovascular and renal hemodynamics and on electrolyte excretion. J Pharmacol Exp Ther (1952) 1.17
Some observations on the pharmacology of hydrochlorothiazide. Am J Cardiol (1959) 1.17
The cardiovascular and renal hemodynamic effects of aramine. Am Heart J (1954) 1.16
Chlorpromazine as a therapeutic agent in clinical medicine. AMA Arch Intern Med (1955) 1.16
Nor-epinephrine; effect in normal subjects; use in treatment of shock unresponsive to other measures. Am J Med (1953) 1.12
Pheochromocytoma in a four-year-old child: renal hemodynamic, pharmacologic, and radiographic studies. J Pediatr (1954) 1.10
Treatment of hypertension with Rauwolfia serpentina alone and combined with other drugs: results in eighty-four cases. J Am Med Assoc (1954) 1.10
Results with oral hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the therapy of hypertension. Am J Med Sci (1953) 1.09
The effect of theophylline with ethylenediamine (aminophylline) on cerebral hemodynamics in the presence of cardiac failure with and without Cheyne-Stokes respiration. J Clin Invest (1952) 1.09
Hyperhydration: a method of decreasing the nephrotoxic effects of Urokon as employed in aortography. Surg Forum (1957) 1.08
Cerebral hemodynamics in patients with heart failure associated and hypertension and the response to treatment. J Clin Invest (1955) 1.07
Unilateral renal adrenergic blockade and the renal response to vasopressor agents and to hemorrhage. J Pharmacol Exp Ther (1954) 1.06
A comparison of the cerebral hemodynamic response to aramine and norepinephrine in the normotensive and hypotensive subject. Circulation (1954) 1.06
Untreated and treated patients with hypertension. Dis Chest (1959) 1.06
Pharmacology of mecamylamine. Am J Med Sci (1956) 1.05
Malignant hypertension and hypertensive encephalopathy. Am J Med (1953) 1.04
PHARMACODYNAMIC EFFECTS OF ALPHA-METHYL DOPA IN HYPERTENSIVE SUBJECTS. Am Heart J (1964) 1.04
Complication of aortography; factors influencing renal function following aoriography with 70 per cent urokon. Surgery (1958) 1.01
Electrolyte, water, and mercury excretion after oral administration of neohydrin; observations on experimental use of neohydrin (1347ex), a chloro derivative, and two thiol (1353ex and 1431ex) derivatives of 2-methoxy-propylurea. AMA Arch Intern Med (1953) 1.00
Reserpine (serpasil) in the treatment of hypertension. Am J Med Sci (1954) 0.99
Effectiveness of aramine in the treatment of shock. Am Heart J (1955) 0.99
A review of the pharmacology and clinical observations of hydrochlorothiazide. Arch Intern Med (1960) 0.98
Drug therapy (mecamylamine) of hypertension. III. Results with mecamylamine, a completely absorbed ganglionic blocking agent. AMA Arch Intern Med (1956) 0.97
Extract of Rauwolfia serpentina in hypertension. GP (1953) 0.97
Further cardiovascular and renal hemodynamic studies following the administration of hydralazine (1-hydrazinophthalazine) and the effect of ganglionic blockade with hexamethonium on these responses. J Pharmacol Exp Ther (1953) 0.97
Renal hemodynamic studies in patients with extensive paralysis; the influence of weight loss, muscle atrophy, and immobilization. J Chronic Dis (1958) 0.97
Treatment of hypertension; results with hexamethonium salts administered orally. Tex State J Med (1952) 0.97
The effect of theophylline with ethylenediamine (aminophylline) and caffeine on cerebral hemodynamics and cerebrospinal fluid pressure in patients with hypertensive headaches. Am J Med Sci (1952) 0.96
Hypothermia. III. The effect of hypothermia on renal damage resulting from ischemia. Ann Surg (1957) 0.96
Toxicity of polymyxin B. II. Human studies with particular reference to evaluation of renal function. AMA Arch Intern Med (1953) 0.95
Hereditary hemorrhagic telangiectases associated with pulmonary arteriovenous fistula in two members of a family. Ann Intern Med (1948) 0.93
Glucose tolerance tests; relative validity of four different types of tests. Tex State J Med (1950) 0.93
The hypnotic effect of a new propanediol dicarbamate, W 583 (a double blind, double dose study). Am J Med Sci (1960) 0.93
Clinical studies of an anti-emetic agent, chlorpromazine. Am J Med Sci (1954) 0.92
The effects of twenty degree head-up tilt upon the cerebral circulation of patients with arterial hypertension before and after sympathectomy. J Clin Invest (1951) 0.92
Human pharmacology of thiazide derivatives. J Am Med Assoc (1959) 0.92
Clinical experience with a new type of orally effective diuretic agent. Clin Pharmacol Ther (1962) 0.92
Significance of the GFR/TmG ratio. Am J Physiol (1955) 0.91
The effect of adrenergic blockade and norepinephrine on renal and cardiovascular hemodynamics following hemorrhage. Circ Res (1954) 0.91
The vascular status of a heterogeneous group of patients with hypertension, with particular emphasis on renal function. Am J Med (1958) 0.91
The renal hemodynamic response to hypothermia and to clamping of the thoracic aorta with and without hypothermia. Surg Forum (1955) 0.91
Laboratory and clinical observations on mecamylamine as a hypotensive agent. Proc Soc Exp Biol Med (1955) 0.91
Experimental and clinical observations on the effects of renal ischemia. Surgery (1956) 0.91
Hypothermia. II. The effect of agents which depress the sympathetic nervous system on the hypothermic induction time and on renal functional alterations due to hypothermia. Ann Surg (1957) 0.90
Cardiovascular and renal hemodynamic response to reserpine (serpasil), and clinical results of using this agent for the treatment of hypertension. Ann N Y Acad Sci (1954) 0.90
Some pharmacological properties of three new mercurial diuretics. Proc Soc Exp Biol Med (1951) 0.90
Renal hemodynamic response to vasopressor agents in the treatment of shock. Circulation (1955) 0.89
Preliminary observations on the antihypertensive properties of guanethidine. Curr Ther Res Clin Exp (1960) 0.88
The differential diagnosis of pulmonary arteriovenous fistula. Dis Chest (1961) 0.88
Decarboxylase inhibitors in the treatment of hypertension. Am J Cardiol (1962) 0.88
MAGNESIUM METABOLISM IN HYPERTENSION. JAMA (1965) 0.87
The effect of a head-up tilted position and ambulation on renal hemodynamics and water and electrolyte excretion in patients with hypertension, with and without renal damage. J Lab Clin Med (1955) 0.87
Changes in sodium and water excretion produced by vaso-active and by ganglionic and adrenergic blocking agents. Am J Physiol (1954) 0.87
Treatment of hypertension with orally and parenterally administered purified extracts of veratrum viride; comparison with ganglionic (Hexamethonium) and adrenergic blocking agents. AMA Arch Intern Med (1952) 0.87
The cardiovascular and renal hemodynamic response to the administration of reserpine (serpasil). Am J Med Sci (1954) 0.86
Preliminary observations of Rauwiloid-hexamethonium combined therapy of hypertension. Am Heart J (1953) 0.86
Effect of morphine and n-allylnormorphine on cerebral hemodynamics and oxygen metabolism. Circulation (1957) 0.86
Hexamethonium in the chronic treatment of hypertension; its effect on renal hemodynamics and on the excretion of water and electrolytes. J Clin Invest (1953) 0.85
Use of d-amphetamine to curb the increased appetite and over-eating induced by reserpine therapy. J Am Geriatr Soc (1956) 0.85
Rauwolfia toxicity in the treatment of hypertension; comparative toxicity of reserpine and alseroxylon. Postgrad Med (1958) 0.85
FIVE YEARS' EXPERIENCE WITH THE EVALUATION OF DIURETIC AGENTS. Circulation (1963) 0.85
Treatment of hypertension in the ambulatory patient. Am J Cardiol (1959) 0.85
Results over a two-year period on three experimental diuretics administered orally to patients with cardiac failure. Am Heart J (1952) 0.85
Effect of increased jugular pressure on cerebral hemodynamics. J Appl Physiol (1954) 0.85
The effect of probenecid (benemid) on phosphate excretion and other metabolic processes. Am J Med Sci (1954) 0.85
A comparative study of four tranquilizing agents, phenobarbital, and inert placebo. Geriatrics (1958) 0.84
Drug therapy (Rauwolfia) of hypertension. II. A comparative study of different extracts of Rauwolfia when each is used alone (orally) for therapy of ambulatory patients with hypertension. AMA Arch Intern Med (1955) 0.84
Blood pressure and renal hemodynamic responses to aramine and the alterations of these responses by adrenergic blockade with dibenzyline. Am Heart J (1954) 0.84
Orally administered hexamethonium chloride in hypertension. J Am Med Assoc (1953) 0.83
Effects of various sympathicomimetic drugs on renal hemodynamics in normotensive and hypotensive dogs. Am J Physiol (1960) 0.83
Kidney function in various thyroid states. J Clin Endocrinol Metab (1961) 0.83